NCT01311752

Brief Summary

This study is a Multicentre cohort study with inclusion throughout the full duration of the study. The primary objective is the study of human papillomavirus related genital pathology in HIV positive women. The secondary objective are:

  1. 1.To study the characteristics of HPV infection and related disease in the context of long term HAART and HIV infection ;
  2. 2.To study the characteristics of atypical cells of uncertain significance detected in Pap smears, whose prevalence has dramatically increased in the last years;
  3. 3.To describe cervical cancers observed in the cohort
  4. 4.To study the evolution of recurrent high-grade lesions after surgery
  5. 5.To describe the evolution of vaginal lesions developed after hysterectomy for high-grade lesions ;
  6. 6.To describe the specific aspects of surgery for the treatment of cervical lesions according to the specific localization in the endocervix in HIV-positive women ;
  7. 7.To study the in situ T cell HPV specific response in cervical lesions and the relationship between virological and clinical parameters, host immune status and natural history of lesions ;
  8. 8.To initiate a prospective study on anal HPV infection and related disease among women infected with HIV.
  9. 9.To initiate a study on therapeutic and/or prophylactic HPV vaccines in the context of immunosuppression and a high rate of HPV infection ;

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
676

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2007

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2010

Completed
8 months until next milestone

First Posted

Study publicly available on registry

March 9, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 27, 2012

Status Verified

December 1, 2012

Enrollment Period

5 years

First QC Date

July 16, 2010

Last Update Submit

December 26, 2012

Conditions

Keywords

human papillomavirusfollow up

Interventions

Clinical, pathological and biological, data at diagnosis and during follow-up will be collected. Surgical sample will be collected to study human papillomavirus related genital pathology.

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample

You may qualify if:

  • women \> 18 years old
  • attending outpatient gynecology consultation
  • HIV positive
  • with written informed consent
  • on social security

You may not qualify if:

  • unaffiliated to the social healthy security french system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Isabelle Heard, MD

    Unité biologie de la reproduction, GH Pitié Salpétrière

    PRINCIPAL INVESTIGATOR
  • Manuella Bonmarchand

    Service Médecine Interne La Pitié Salpétrière

    PRINCIPAL INVESTIGATOR
  • Roland Tubiana

    Service maladies infectieuses La Pitié Salpétrière

    PRINCIPAL INVESTIGATOR
  • Ana Canestri

    Service maladies infectieuses La Pitié Salpétrière

    PRINCIPAL INVESTIGATOR
  • Catherine Creen Hebert

    Service Gynécologie-obstétrique Louis Mourier

    PRINCIPAL INVESTIGATOR
  • Laurent Mandelbrot

    Service Gynécologie Louis Mourier

    PRINCIPAL INVESTIGATOR
  • Francoise Meier

    Service Gynécologie Louis Mourier

    PRINCIPAL INVESTIGATOR
  • Elisabeth Foucher

    Service Gynécologie Louis Mourier

    PRINCIPAL INVESTIGATOR
  • Marie Jeanne Ducassou

    Hopital de jour CISIH Marseille

    PRINCIPAL INVESTIGATOR
  • Isabelle Poizot Martin

    Hôpital de jour CISIH Marseille

    PRINCIPAL INVESTIGATOR
  • Bénédicte Lefèvre

    Service des maladies infectieuses St Antoine

    PRINCIPAL INVESTIGATOR
  • Bruno Carbonne

    Service Gynécologie St Antoine

    PRINCIPAL INVESTIGATOR
  • Dahlia Torchin

    Service Gynécologie St Antoine

    PRINCIPAL INVESTIGATOR
  • Anne Isabelle Richet

    Service Gynécologie St Antoine

    PRINCIPAL INVESTIGATOR
  • Jean Paul Viard

    centre de diagnostic et thérapeutique Hopital Hotel Dieu

    PRINCIPAL INVESTIGATOR
  • Christine Rousset Jablonski

    Service Gynécologie Obstétrique Hopital Hotel Dieu

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2010

First Posted

March 9, 2011

Study Start

November 1, 2007

Primary Completion

November 1, 2012

Study Completion

December 1, 2012

Last Updated

December 27, 2012

Record last verified: 2012-12